Johannes Czernin, M.D.

Office Address:
AR-243 CHS, 10833 LeConte Ave
Campus - 694215
Los Angeles, CA 90095

Work Address:
B114 Suite, 200 Medical Plaza
Los Angeles, CA 90095

Affiliations
Affiliations
Director, Nuclear Medicine Clinic, Positron Emission Tomography/Computed Tomography
Professor, Medicine
Associate Director, JCCC Cancer Molecular Imaging
Professor and Vice Chair, Molecular & Medical Pharmacology
Member, Cardiology, DOE Funded Faculty, Molecular Pharmacology GPB Home Area, themes
Faculty, Crump Institute for Molecular Imaging
Research Interests
Dr. Johannes Czernin got his MD in Medicine from the University of Vienna, Austria in 1983. He is currently Chief of the Ahmanson Translational Imaging Division, Professor of Molecular and Medical Pharmacology/Nuclear Medicine, and Vice-Chair of the Department at the University of California, School of Medicine, Department of Molecular and Medical Pharmacology. Dr. Czernin and his colleague Dr. Caius Radu have established an exciting and well funded research environment, the Ahmanson Translational Imaging Division which has grown substantially over the last several years and consists of the Nuclear Medicine Clinic, a Clinical Imaging Research Program, and a new preclinical imaging center. The success of the Division is based on extensive collaborations within the department of molecular and medical pharmacology and across several other departments including medicine, surgery, radiology, neurology, pathology and others. Dr. Czernin in his capacity of Division chief is responsible for multiple clinic sites within the UCLA Medical Enterprise. The total number of clinical and research PET/CT scans performed approaches 4500/year. Conventional nuclear medicine services are offered at both Westwood and Santa Monica hospitals for more than 10,000 patients/year, cardiac imaging sites in Santa Monica and Westwood serve close to 3,000 patients/year. Significant portions of the clinical revenue are invested in research programs within and outside the division. Dr. Czernin was the President of the Academy of Molecular Imaging for 2 years and has been on the board of the Academy for the past 6 years. Over the past three years Dr. Czernin has been designed and serves as the Principal Investigator of a large multicenter trial of 18F-NaF for imaging of bone metastases that is sponsored by the World Molecular Imaging Society. This on-going clinical trial includes 19 sites world- and 400 patients have been enrolled. The data from this trial will be used to help CMS and other payers make decisions about coverage for 18F-Sodium Fluoride for bone imaging in cancer patients.
Biography:

The major focus of this team research is the development of a translational theranostics program and the identification of effective combination between radioligand therapies and pharmacologic approaches. The current focus is prostate cancer to improve the results of radionuclide (radioligand) therapies that requires an understanding of resistance mechanisms that limit the effectiveness of theranostic approaches. To address these issues the Ahmanson Translational Theranostics Division encompasses in vitro, animal experimental and clinical research and focuses on translating in vitro findings into in vivo applications. Available research tools include among others Mass Spcetrometers for proteomic and phosphoproteomic analyses; preclinical PET/CT and bioluminescence imaging; wet labs, a cell culture lab, and a vivarium.

Publications

A selected list of publications:

Schwarzenberg Johannes, Czernin Johannes, Cloughesy Timothy F, Ellingson Benjamin M, Pope Whitney B, Geist Cheri, Dahlbom Magnus, Silverman Daniel H S, Satyamurthy Nagichettiar, Phelps Michael E, Chen Wei   3'-Deoxy-3'-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012; 53(1): 29-36.
Karantanis Dimitrios, Allen-Auerbach Martin, Czernin Johannes   Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma Clinical nuclear medicine, 2012; 37(1): 49-53.
Campbell Dean O, Yaghoubi Shahriar S, Su Ying, Lee Jason T, Auerbach Martin S, Herschman Harvey, Satyamurthy Nagichettiar, Czernin Johannes, Lavie Arnon, Radu Caius G   Structure-guided Engineering of Human Thymidine Kinase 2 as a Positron Emission Tomography Reporter Gene for Enhanced Phosphorylation of Non-natural Thymidine Analog Reporter Probe The Journal of biological chemistry, 2012; 287(1): 446-54.
Benz Matthias R, Herrmann Ken, Walter Franziska, Garon Edward B, Reckamp Karen L, Figlin Robert, Phelps Michael E, Weber Wolfgang A, Czernin Johannes, Allen-Auerbach Martin S   (18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011; 52(11): 1684-9.
Walter Franziska, Federman Noah, Apichairuk Wipapat, Nelson Scott, Phelps Michael E, Allen-Auerbach Martin, Walter Martin A, Czernin Johannes   18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients Pediatric hematology and oncology, 2011; 28(7): 579-87.
Benz Matthias R, Czernin Johannes, Allen-Auerbach Martin S, Dry Sarah M, Sutthiruangwong Piriya, Spick Claudio, Radu Caius, Weber Wolfgang A, Tap William D, Eilber Fritz C   3'-deoxy-3'-[(18) F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: A pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response Cancer, 2011; 52(11): .
Czernin Johannes, Benz Matthias R, Allen-Auerbach Martin S   Breast cancer Methods in molecular biology (Clifton, N.J.), 2011; 727(1): 141-70.
Ng Quinn K T, Su Helen, Armijo Amanda Lee, Czernin Johannes, Radu Caius G, Segura Tatiana   Clustered Arg-Gly-Asp peptides enhances tumor targeting of nonviral vectors ChemMedChem, 2011; 6(4): 623-7.
Yang Yang, Czernin Johannes   Contribution of imaging to cancer care costs Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011; 52 Suppl 2(1): 86S-92S.
Wardak Mirwais, Schiepers Christiaan, Dahlbom Magnus, Cloughesy Timothy, Chen Wei, Satyamurthy Nagichettiar, Czernin Johannes, Phelps Michael E, Huang Sung-Cheng   Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma Clinical cancer research : an official journal of the American Association for Cancer Research, 2011; 17(20): 6553-62.
Schwarzenberg Johannes, Radu Caius G, Benz Matthias, Fueger Barbara, Tran Andrew Q, Phelps Michael E, Witte Owen N, Satyamurthy Nagichettiar, Czernin Johannes, Schiepers Christiaan   Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway European journal of nuclear medicine and molecular imaging, 2011; 38(4): 711-21.
Walter Franziska, Czernin Johannes, Hall Theodore, Allen-Auerbach Martin, Walter Martin A, Dunkelmann Simone, Federman Noah   Is There a Need for Dedicated Bone Imaging in Addition to 18F-FDG PET/CT Imaging in Pediatric Sarcoma Patients? Journal of pediatric hematology/oncology, 2011; 52 Suppl 2(1): .
Czernin Johannes, Weber Wolfgang A   Issues and controversies in nuclear medicine. Introduction Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011; 52 Suppl 2(1): 1S-2S.
Walter Martin A, Benz Matthias R, Hildebrandt Isabel J, Laing Rachel E, Hartung Verena, Damoiseaux Robert D, Bockisch Andreas, Phelps Michael E, Czernin Johannes, Weber Wolfgang A   Metabolic imaging allows early prediction of response to vandetanib Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011; 52(2): 231-40.
Maddahi Jamshid, Czernin Johannes, Lazewatsky Joel, Huang Sung-Cheng, Dahlbom Magnus, Schelbert Heinrich, Sparks Richard, Ehlgen Alexander, Crane Paul, Zhu Qi, Devine Marybeth, Phelps Michael   Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011; 52(9): 1490-8.
Macapinlac Homer A, Czernin Johannes, Larson Steven M   Practice based evidence of the beneficial impact of PET in patients with brain tumors Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2011; 13(1): 1-2.
Beyer Thomas, Czernin Johannes, Freudenberg Lutz S   Variations in clinical PET/CT operations: results of an international survey of active PET/CT users Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011; 52(2): 303-10.
Benz Matthias R, Dry Sarah M, Eilber Fritz C, Allen-Auerbach Martin S, Tap William D, Elashoff David, Phelps Michael E, Czernin Johannes   Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010; 51(8): 1174-81.
Fueger Barbara J, Czernin Johannes, Cloughesy Timothy, Silverman Daniel H, Geist Cheri L, Walter Martin A, Schiepers Christiaan, Nghiemphu Phioanh, Lai Albert, Phelps Michael E, Chen Wei   Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010; 51(10): 1532-8.
Benz Matthias R, Czernin Johannes, Tap William D, Eckardt Jeffrey J, Seeger Leanne L, Allen-Auerbach Martin S, Dry Sarah M, Phelps Michael E, Weber Wolfgang A, Eilber Fritz C   FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas Sarcoma, 2010; 2010(2): 143540.
Ribas Antoni, Benz Matthias R, Allen-Auerbach Martin S, Radu Caius, Chmielowski Bartosz, Seja Elizabeth, Williams John L, Gomez-Navarro Jesus, McCarthy Timothy, Czernin Johannes   Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010; 51(3): 340-6.
Beyer Thomas, Czernin Johannes   Is conflict of interest in our best interest? European journal of nuclear medicine and molecular imaging, 2010; 37(6): 1063-8.
Schiepers Christiaan, Dahlbom Magnus, Chen Wei, Cloughesy Timothy, Czernin Johannes, Phelps Michael E, Huang Sung-Cheng   Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010; 51(5): 720-7.
Czernin Johannes, Satyamurthy Nagichettiar, Schiepers Christiaan   Molecular mechanisms of bone 18F-NaF deposition Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010; 51(12): 1826-9.
Shu Chengyi J, Campbell Dean O, Lee Jason T, Tran Andrew Q, Wengrod Jordan C, Witte Owen N, Phelps Michael E, Satyamurthy Nagichettiar, Czernin Johannes, Radu Caius G   Novel PET probes specific for deoxycytidine kinase Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010; 51(7): 1092-8.
Czernin Johannes, Benz Matthias R, Allen-Auerbach Martin S   PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination European journal of radiology, 2010; 73(3): 470-80.
Benz Matthias R, Czernin Johannes, Dry Sarah M, Tap William D, Allen-Auerbach Martin S, Elashoff David, Phelps Michael E, Weber Wolfgang A, Eilber Fritz C   Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign Cancer, 2010; 116(2): 451-8.
Toy Gerald, Austin Wayne R, Liao Hsiang-I, Cheng Donghui, Singh Arun, Campbell Dean O, Ishikawa Tomo-o, Lehmann Lynn W, Satyamurthy Nagichettiar, Phelps Michael E, Herschman Harvey R, Czernin Johannes, Witte Owen N, Radu Caius G   Requirement for deoxycytidine kinase in T and B lymphocyte development Proceedings of the National Academy of Sciences of the United States of America, 2010; 107(12): 5551-6.
Walter Martin A, Hildebrandt Isabel J, Hacke Katrin, Kesner Adam L, Kelly Owen, Lawson Gregory W, Phelps Michael E, Czernin Johannes, Weber Wolfgang A, Schiestl Robert H   Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010; 51(8): 1285-92.
Imani Farzin, Agopian Vatche G, Auerbach Martin S, Walter Martin A, Imani Firoozeh, Benz Matthias R, Dumont Rebecca A, Lai Chi Kien, Czernin Johannes G, Yeh Michael W   18F-FDOPA PET and PET/CT accurately localize pheochromocytomas Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009; 50(4): 513-9.
Ledezma Carlos J, Chen Wei, Sai Victor, Freitas Bonnie, Cloughesy Tim, Czernin Johannes, Pope Whitney   18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience European journal of radiology, 2009; 71(2): 242-8.
Wang Hao, Wang Shutao, Su Helen, Chen Kuan-Ju, Armijo Amanda Lee, Lin Wei-Yu, Wang Yanju, Sun Jing, Kamei Ken-ichiro, Czernin Johannes, Radu Caius G, Tseng Hsian-Rong   A supramolecular approach for preparation of size-controlled nanoparticles Angewandte Chemie (International ed. in English), 2009; 48(24): 4344-8.
Fueger Barbara J, Yeom Kristen, Czernin Johannes, Sayre James W, Phelps Michael E, Allen-Auerbach Martin S   Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2009; 11(4): 269-74.
Benz Matthias R, Czernin Johannes, Allen-Auerbach Martin S, Tap William D, Dry Sarah M, Elashoff David, Chow Kira, Evilevitch Vladimir, Eckardt Jeff J, Phelps Michael E, Weber Wolfgang A, Eilber Fritz C   FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas Clinical cancer research : an official journal of the American Association for Cancer Research, 2009; 15(8): 2856-63.
Yaghoubi Shahriar S, Jensen Michael C, Satyamurthy Nagichettiar, Budhiraja Shradha, Paik David, Czernin Johannes, Gambhir Sanjiv S   Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma Nature clinical practice. Oncology, 2009; 6(1): 53-8.
Dumont Rebecca A, Hildebrandt Isabel, Su Helen, Haubner Roland, Reischl Gerald, Czernin Johannes G, Mischel Paul S, Weber Wolfgang A   Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib Cancer research, 2009; 69(7): 3173-9.
Laing Rachel E, Walter Martin A, Campbell Dean O, Herschman Harvey R, Satyamurthy Nagichettiar, Phelps Michael E, Czernin Johannes, Witte Owen N, Radu Caius G   Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography Proceedings of the National Academy of Sciences of the United States of America, 2009; 106(8): 2847-52.
Czernin Johannes, Benz Matthias R, Allen-Auerbach Martin S   PET Imaging of Prostate Cancer Using C-Acetate PET clinics, 2009; 4(2): 163-172.
Schluep Thomas, Hwang Jungyeon, Hildebrandt Isabel J, Czernin Johannes, Choi Chung Hang J, Alabi Christopher A, Mack Brendan C, Davis Mark E   Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements Proceedings of the National Academy of Sciences of the United States of America, 2009; 106(27): 11394-9.
Guo Deliang, Hildebrandt Isabel J, Prins Robert M, Soto Horacio, Mazzotta Mary M, Dang Julie, Czernin Johannes, Shyy John Y-J, Watson Andrew D, Phelps Michael, Radu Caius G, Cloughesy Timothy F, Mischel Paul S   The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis Proceedings of the National Academy of Sciences of the United States of America, 2009; 106(31): 12932-7.
Johnson Mai, Karanikolas Breanne D W, Priceman Saul J, Powell Russell, Black Margaret E, Wu Hsiao-Ming, Czernin Johannes, Huang Sung-Cheng, Wu Lily   Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009; 50(5): 757-64.
Benz Matthias R, Tchekmedyian Nishan, Eilber Fritz C, Federman Noah, Czernin Johannes, Tap William D   Utilization of positron emission tomography in the management of patients with sarcoma Current opinion in oncology, 2009; 21(4): 345-51.
Wei Liu Hua, Su Helen, Hildebrandt Isabel J, Phelps Michael E, Czernin Johannes, Weber Wolfgang A   Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma Clinical cancer research : an official journal of the American Association for Cancer Research, 2008; 14(11): 3416-26.
Benz Matthias R, Allen-Auerbach Martin S, Eilber Fritz C, Chen Hui J J, Dry Sarah, Phelps Michael E, Czernin Johannes, Weber Wolfgang A   Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008; 49(10): 1579-84.
Wei Liu H, Olafsen Tove, Radu Caius, Hildebrandt Isabel J, McCoy Mark R, Phelps Michael E, Meares Claude, Wu Anna M, Czernin Johannes, Weber Wolfgang A   Engineered antibody fragments with infinite affinity as reporter genes for PET imaging Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008; 49(11): 1828-35.
Su Helen, Seimbille Yann, Ferl Gregory Z, Bodenstein Claudia, Fueger Barbara, Kim Kevin J, Hsu Yu-Tien, Dubinett Steven M, Phelps Michael E, Czernin Johannes, Weber Wolfgang A   Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors European journal of nuclear medicine and molecular imaging, 2008; 35(6): 1089-99.
Kesner Adam L, Hsueh Wei-Ann, Czernin Johannes, Padgett Henry, Phelps Michael E, Silverman Daniel H S   Radiation dose estimates for [18F]5-fluorouracil derived from PET-based and tissue-based methods in rats Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2008; 10(6): 341-8.
Evilevitch Vladimir, Weber Wolfgang A, Tap William D, Allen-Auerbach Martin, Chow Kira, Nelson Scott D, Eilber Fredrick R, Eckardt Jeffery J, Elashoff Robert M, Phelps Michael E, Czernin Johannes, Eilber Fritz C   Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas Clinical cancer research : an official journal of the American Association for Cancer Research, 2008; 14(3): 715-20.
Weber Wolfgang A, Grosu Anca L, Czernin Johannes   Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning Nature clinical practice. Oncology, 2008; 5(3): 160-70.
Weber Wolfgang A, Czernin Johannes, Phelps Michael E, Herschman Harvey R   Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs Nature clinical practice. Oncology, 2008; 5(1): 44-54.
Allen-Auerbach Martin, de Vos Sven, Czernin Johannes   The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients Radiologic clinics of North America, 2008; 46(2): 199-211, vii.
Kesner Adam L, Lau Victoria K, Speiser Michael, Hsueh Wei-Ann, Agazaryan Nzhde, DeMarco John J, Czernin Johannes, Silverman Daniel H S   Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow Journal of applied clinical medical physics / American College of Medical Physics, 2008; 9(3): 2747.
Benz Matthias R, Evilevitch Vladimir, Allen-Auerbach Martin S, Eilber Fritz C, Phelps Michael E, Czernin Johannes, Weber Wolfgang A   Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008; 49(7): 1038-46.
Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J   Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2005; 46(1): 114-20.
Halpern BS, Dahlbom M, Waldherr C, Yap CS, Schiepers C, Silverman DH, Ratib O, Czernin J   Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2004; 45(2): 290-3.
Allen-Auerbach M, Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J   Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma Mol Imaging Biol, 2004; 6(6): 411-6.
Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J   Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease Mol Imaging Biol, 2004; 6(1): 47-54.
Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J   Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2004; 45(5): 797-801.
Obrzut SL, Halpern BS, Monchamp T, Grabski K, Watts WJ, Czernin J   The role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor Mol Imaging Biol, 2004; 6(3): 126-30.
Czernin J, Weber W   Translational molecular imaging Mol Imaging Biol, 2004; 6(4): 181-2.
Czernin J, Waldherr C   Cigarette smoking and coronary blood flow Progress in cardiovascular diseases. , 2003; 45(5): 395-404.
Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J   Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients Mol Imaging Biol, 2003; 5(4): 232-9.
Pio BS, Byrne FR, Aranda R, Boulay G, Spicher K, Song MH, Birnbaumer L, Phelps ME, Czernin J, Silverman DH.   Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells, Mol Imaging Biol. , 2003; 5(4):: 271-7. .
Schiepers C, Filmont JE, Czernin J   PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma Eur J Nucl Med Mol Imaging, 2003; 30 Suppl 1: S82-8.
Silverman DH, Truong CT, Kim SK, Chang CY, Chen W, Kowell AP, Cummings JL, Czernin J, Small GW, Phelps ME.   Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET, Mol Genet Metab. , 2003; 80(3):: 350-5. .
Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J   Relationship between 18F-FDG uptake and breast density in women with normal breast tissue Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2003; 44(8): 1238-42.
Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C   Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation Chest. , 2003; 124(2): 608-13.
Schoder H, Brown K, Said J, Czernin J   A Patient with Primary Cardiac Lymphoma, J Mol Imag Biol. , 2002; 4(4):: 274-275.
Silverman DH, Cummings JL, Small GW, Gambhir SS, Chen W, Czernin J, Phelps ME.   Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment, Mol Imaging Biol. , 2002; 4(4):: 283-93. .
Czernin J   Clinical applications of FDG-PET in oncology Acta medica Austriaca. , 2002; 29(5): 162-70.
Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, Chodosh J, Czernin J, Phelps ME   Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2002; 43(2): 253-66.
Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J   FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? European journal of nuclear medicine and molecular imaging. , 2002; 29(9): 1166-73.
Czernin J   FDG-PET in breast cancer: a different view of its clinical usefulness Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. , 2002; 4(1): 35-45.
Wong C, Silverman DH, Seltzer M, Schiepers C, Arianejad M, Gambhir SS, Phelps ME, Rao J, Valk P, Czernin J   The Impact of 2-deoxy-2[F-18]fluoro-D-glucose (FDG) Whole Body Positron Emission Tomography (PET) for Managing Patients with Melanoma: The Referring Physician?s Perspective, Mol Imag Biol. , 2002; 4(2): : 185-190. .
Seltzer MA, Yap C, Silverman DH, Meta J, Schiepers C, Phelps ME, Sayre J, Ariannejad M, Gambhir SS, Rao J, Valk PE, Czernin J   The Impact of Positron Emission Tomography on the Management of Patients with Lung Cancer: The Referring Physician?s Perspective, J Nucl Med. , 2002; 43(6): : 752-56..
Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J   The Usefulness of F-18 Deoxy-Glucose Whole Body Positron Emission Tomography (PET) for Re-Staging of Renal Cell Cancer, , 2002; 57(1): : 56-62..
Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J   Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2002; 43(3): 325-9.
Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME   A tabulated summary of the FDG PET literature Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2001; 42(5 Suppl): 1S-93S.
Kwan A, Seltzer M, Czernin J, Chou MJ, Kao CH   Characterization of hilar lymph node by 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects Anticancer research. , 2001; 21(1B): 701-6.
Park KC, Schwimmer J, Shepherd JE, Phelps ME, Czernin JR, Schiepers C, Gambhir SS   Decision analysis for the cost-effective management of recurrent colorectal cancer Annals of surgery. , 2001; 233(3): 310-9.
Schoder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J   Effect of the whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma, J Nucl Med, 2001; 42(8): : 1139-43..
Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J   Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2001; 42(4): 586-90.
Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J   Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2001; 42(9): 1334-7.
Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME   Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome JAMA : the journal of the American Medical Association. , 2001; 286(17): 2120-7.
Madsen MM, Bottcher M, Toftegaard Nielsen T, Czernin J   . Altered regulation of the myocardial microcirculation in young smokers, Cardiology. , 2000; 94(2): : 91-8..
Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS   A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer Journal of nuclear medicine : official publication, Society of Nuclear Medicine. , 2000; 41(7): 1177-89.
Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, Phelps ME, Czernin J, Gambhir SS   A review of the literature for whole-body FDG PET in the management of patients with melanoma The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). , 2000; 44(2): 153-67.
Allen-Auerbach M, Schoder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, Silverman D, Phelps ME, Schelbert HR, Czernin J.   Prevalence of myocardial viability as detected by PET in patients with ischemic cardiomyopathy, Circulation, 1999; 99(22):: 2921-26.
Bluemel Christina, Krebs Markus, Polat Bülent, Linke Fränze, Eiber Matthias, Samnick Samuel, Lapa Constantin, Lassmann Michael, Riedmiller Hubertus, Czernin Johannes, Rubello Domenico, Bley Thorsten, Kropf Saskia, Wester Hans-Juergen, Buck Andreas K, Herrmann Ken   68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT Clinical nuclear medicine, 2016; 41(7): 515-21.
Kim Woosuk, Le Thuc M, Wei Liu, Poddar Soumya, Bazzy Jimmy, Wang Xuemeng, Uong Nhu T, Abt Evan R, Capri Joseph R, Austin Wayne R, Van Valkenburgh Juno S, Steele Dalton, Gipson Raymond M, Slavik Roger, Cabebe Anthony E, Taechariyakul Thotsophon, Yaghoubi Shahriar S, Lee Jason T, Sadeghi Saman, Lavie Arnon, Faull Kym F, Witte Owen N, Donahue Timothy R, Phelps Michael E, Herschman Harvey R, Herrmann Ken, Czernin Johannes, Radu Caius G   [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity Proceedings of the National Academy of Sciences of the United States of America, 2016; 113(15): 4027-32.
Spick Claudio, Herrmann Ken, Czernin Johannes   18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016; 57(3): 420-30.
Czernin Johannes, Mankoff David   Introduction and Overview Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016; 57 Suppl 1(3): 1S-2S.
Czernin Johannes   Reply: Roundtable on the Future of Nuclear Medicine Training Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015; 56(12): 1969-70.
Herrmann Ken, Bluemel Christina, Weineisen Martina, Schottelius Margret, Wester Hans-Jürgen, Czernin Johannes, Eberlein Uta, Beykan Seval, Lapa Constantin, Riedmiller Hubertus, Krebs Markus, Kropf Saskia, Schirbel Andreas, Buck Andreas K, Lassmann Michael   Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015; 56(6): 855-61.
Karavaeva Elena, Harris Robert J, Leu Kevin, Shabihkhani Maryam, Yong William H, Pope Whitney B, Lai Albert, Nghiemphu Phioanh L, Liau Linda M, Chen Wei, Czernin Johannes, Cloughesy Timothy F, Ellingson Benjamin M   Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2015; 17(3): 434-42.
Herrmann Ken, Czernin Johannes, Wolin Edward M, Gupta Pawan, Barrio Martin, Gutierrez Antonio, Schiepers Christiaan, Mosessian Sherly, Phelps Michael E, Allen-Auerbach Martin S   Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015; 56(1): 70-5.
Karantanis Dimitrios, Kalkanis Dimitrios, Czernin Johannes, Herrmann Ken, Pomykala Kelsey L, Bogsrud Trond V, Subramaniam Rathan M, Lowe Val J, Allen-Auerbach Martin S   Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014; 55(12): 1925-9.
Nomme Julian, Li Zheng, Gipson Raymond M, Wang Jue, Armijo Amanda L, Le Thuc, Poddar Soumya, Smith Tony, Santarsiero Bernard D, Nguyen Hien-Anh, Czernin Johannes, Alexandrova Anastassia N, Jung Michael E, Radu Caius G, Lavie Arnon   Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability Journal of medicinal chemistry, 2014; 57(22): 9480-94.
Lapa Constantin, Linsenmann Thomas, Monoranu Camelia Maria, Samnick Samuel, Buck Andreas K, Bluemel Christina, Czernin Johannes, Kessler Almuth F, Homola Gyoergy A, Ernestus Ralf-Ingo, Löhr Mario, Herrmann Ken   Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014; 55(10): 1611-6.
Packard René R S, Huang Sung-Cheng, Dahlbom Magnus, Czernin Johannes, Maddahi Jamshid   Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014; 55(9): 1438-44.
Mosessian Sherly, Duarte-Vogel Sandra M, Stout David B, Roos Kenneth P, Lawson Gregory W, Jordan Maria C, Ogden Amanda, Matter Cheryl, Sadeghi Saman, Mills George Q, Schelbert Heinrich R, Radu Caius G, Czernin Johannes, Couto Marcelo, Phelps Michael E   INDs for PET molecular imaging probes-approach by an academic institution Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2014; 16(4): 441-8.
Wieder Hinrich A, Lassmann Michael, Allen-Auerbach Martin S, Czernin Johannes, Herrmann Ken   Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters World journal of radiology, 2014; 6(7): 480-5.
Lajtos Imre, Czernin Johannes, Dahlbom Magnus, Daver Freddie, Emri Miklos, Farshchi-Heydari Salman, Forgacs Attila, Hoh Carl K, Joszai Istvan, Krizsan Aron K, Lantos Judit, Major Peter, Molnar Jozsef, Opposits Gabor, Tron Lajos, Vera David R, Balkay Laszlo   Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom Physics in medicine and biology, 2014; 59(11): 2727-46.
Schwarzenberg Johannes, Czernin Johannes, Cloughesy Timothy F, Ellingson Benjamin M, Pope Whitney B, Grogan Tristan, Elashoff David, Geist Cheri, Silverman Daniel H S, Phelps Michael E, Chen Wei   Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy Clinical cancer research : an official journal of the American Association for Cancer Research, 2014; 20(13): 3550-9.
Czernin Johannes, Ta Lisa, Herrmann Ken   Does PET/MR Imaging Improve Cancer Assessments? Literature Evidence from More Than 900 Patients Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014; 55(Supplement 2): 59S-62S.
Czernin Johannes, Schwaiger Markus, Townsend David   Introduction Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014; 55(Supplement 2): 1S.
Bailey Dale L, Barthel Henryk, Beuthin-Baumann Bettina, Beyer Thomas, Bisdas Sotirios, Boellaard Ronald, Czernin Johannes, Drzezga Alexander, Ernemann Ulrike, Franzius Christiane, Gückel Brigitte, Handgretinger Rupert, Hartenbach Markus, Hellwig Dirk, Nadel Helen, Nekolla Stephan G, Pfluger Thomas, Pichler Bernd J, Quick Harald H, Sabri Osama, Sattler Bernhard, Schäfer Jürgen, Schick Fritz, Siegel Barry A, Schlemmer Heinz P, Schwenzer Nina F, van den Hoff Jörg, Veit-Haibach Patrick, Wehrl Hans F   Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2014; 16(3): 295-310.
Chodon Thinle, Comin-Anduix Begoña, Chmielowski Bartosz, Koya Richard C, Wu Zhongqi, Auerbach Martin, Ng Charles, Avramis Earl, Seja Elizabeth, Villanueva Arturo, McCannel Tara A, Ishiyama Akira, Czernin Johannes, Radu Caius G, Wang Xiaoyan, Gjertson David W, Cochran Alistair J, Cornetta Kenneth, Wong Deborah J L, Kaplan-Lefko Paula, Hamid Omid, Samlowski Wolfram, Cohen Peter A, Daniels Gregory A, Mukherji Bijay, Yang Lili, Zack Jerome A, Kohn Donald B, Heath James R, Glaspy John A, Witte Owen N, Baltimore David, Economou James S, Ribas Antoni   Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma Clinical cancer research : an official journal of the American Association for Cancer Research, 2014; 20(9): 2457-65.
Herrmann Ken, Czernin Johannes, Cloughesy Timothy, Lai Albert, Pomykala Kelsey L, Benz Matthias R, Buck Andreas K, Phelps Michael E, Chen Wei   Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients Neuro-oncology, 2014; 16(4): 603-9.
Nathanson David A, Armijo Amanda L, Tom Michelle, Li Zheng, Dimitrova Elizabeth, Austin Wayne R, Nomme Julian, Campbell Dean O, Ta Lisa, Le Thuc M, Lee Jason T, Darvish Ryan, Gordin Ari, Wei Liu, Liao Hsiang-I, Wilks Moses, Martin Colette, Sadeghi Saman, Murphy Jennifer M, Boulos Nidal, Phelps Michael E, Faull Kym F, Herschman Harvey R, Jung Michael E, Czernin Johannes, Lavie Arnon, Radu Caius G   Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication The Journal of experimental medicine, 2014; 211(3): 473-86.
Javed Muhammad Rashed, Chen Supin, Kim Hee-Kwon, Wei Liu, Czernin Johannes, Kim Chang-Jin C J, van Dam R Michael, Keng Pei Yuin   Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014; 55(2): 321-8.
Lapa Constantin, Linz Christian, Bluemel Christina, Mottok Anja, Mueller-Richter Urs, Kuebler Alexander, Schneider Peter, Czernin Johannes, Buck Andreas K, Herrmann Ken   Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw Clinical nuclear medicine, 2014; 39(1): 21-5.
Murphy Jennifer M, Armijo Amanda L, Nomme Julian, Lee Chi Hang, Smith Quentin A, Li Zheng, Campbell Dean O, Liao Hsiang-I, Nathanson David A, Austin Wayne R, Lee Jason T, Darvish Ryan, Wei Liu, Wang Jue, Su Ying, Damoiseaux Robert, Sadeghi Saman, Phelps Michael E, Herschman Harvey R, Czernin Johannes, Alexandrova Anastassia N, Jung Michael E, Lavie Arnon, Radu Caius G   Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography Journal of medicinal chemistry, 2013; 56(17): 6696-708.
Lizarraga Karlo J, Allen-Auerbach Martin, Czernin Johannes, DeSalles Antonio A F, Yong William H, Phelps Michael E, Chen Wei   (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014; 55(1): 30-6.
Allen-Auerbach Martin, de Vos Sven, Czernin Johannes   PET/computed tomography and lymphoma Radiologic clinics of North America, 2013; 51(5): 833-44.
Amaraesekera Bernard, Marchis Phillip D, Bobinski Krzysztof P, Radu Caius G, Czernin Johannes, Barrio Jorge R, Michael van Dam R   High-pressure, compact, modular radiosynthesizer for production of positron emitting biomarkers Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2013; 78(5): 88-101.
Czernin Johannes, Herrmann Ken   The potential of PET/MRI imaging in oncology: a comment to a summary report of the First PET/MRI Workshop in Tuebingen in 2012 Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2013; 15(4): 372-3.
Herrmann Ken, Dahlbom Magnus, Nathanson David, Wei Liu, Radu Caius, Chatziioannou Arion, Czernin Johannes   Evaluation of the Genisys4, a bench-top preclinical PET scanner Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013; 54(7): 1162-7.
Czernin Johannes, Allen-Auerbach Martin, Nathanson David, Herrmann Ken   PET/CT in Oncology: Current Status and Perspectives Current radiology reports, 2013; 1(7): 177-190.
Ellingson Benjamin M, Chen Wei, Harris Robert J, Pope Whitney B, Lai Albert, Nghiemphu Phioanh L, Czernin Johannes, Phelps Michael E, Cloughesy Timothy F   PET Parametric Response Mapping for Clinical Monitoring and Treatment Response Evaluation in Brain Tumors PET clinics, 2013; 8(2): 201-17.
Shackelford David B, Abt Evan, Gerken Laurie, Vasquez Debbie S, Seki Atsuko, Leblanc Mathias, Wei Liu, Fishbein Michael C, Czernin Johannes, Mischel Paul S, Shaw Reuben J   LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin Cancer cell, 2013; 23(2): 143-58.
Berman Daniel S, Maddahi Jamshid, Tamarappoo B K, Czernin Johannes, Taillefer Raymond, Udelson James E, Gibson C Michael, Devine Marybeth, Lazewatsky Joel, Bhat Gajanan, Washburn Dana   Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography Journal of the American College of Cardiology, 2013; 61(4): 469-77.
Austin Wayne R, Armijo Amanda L, Campbell Dean O, Singh Arun S, Hsieh Terry, Nathanson David, Herschman Harvey R, Phelps Michael E, Witte Owen N, Czernin Johannes, Radu Caius G   Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress The Journal of experimental medicine, 2012; 209(12): 2215-28.
Mocharla Vani P, Walsh Joseph C, Padgett Henry C, Su Helen, Fueger Barbara, Weber Wolfgang A, Czernin Johannes, Kolb Hartmuth C   From in situ to in vivo: an in situ click-chemistry-derived carbonic anhydrase II imaging agent for positron emission tomography ChemMedChem, 2013; 8(1): 43-8.
Karantanis Dimitrios, Kalkanis Dimitrios, Allen-Auerbach Martin, Bogsrud Trond Velde, Subramaniam Rathan M, Danielson Adam, Lowe Val J, Czernin Johannes   Oncologic 18F-FDG PET/CT: referring physicians' point of view Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012; 53(10): 1499-505.
Harris Robert J, Cloughesy Timothy F, Pope Whitney B, Nghiemphu Phioanh L, Lai Albert, Zaw Taryar, Czernin Johannes, Phelps Michael E, Chen Wei, Ellingson Benjamin M   18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab Neuro-oncology, 2012; 14(8): 1079-89.
Lee Percy, Kupelian Patrick, Czernin Johannes, Ghosh Partha   Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer Frontiers in oncology, 2012; 2(8): 71.
Karantanis Dimitrios, Allen-Auerbach Martin, Czernin Johannes   Squamous papilloma of the oral cavity and oropharynx on 18F-FDG PET/CT imaging Clinical nuclear medicine, 2012; 37(5): e98-9.
Herschman Harvey R, Czernin Johannes   A spotlight from prostate cancer Cancer discovery, 2012; 2(4): 301-3.
Herrmann Ken, Benz Matthias R, Czernin Johannes, Allen-Auerbach Martin S, Tap William D, Dry Sarah M, Schuster Tibor, Eckardt Jeff J, Phelps Michael E, Weber Wolfgang A, Eilber Fritz C   18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy Clinical cancer research : an official journal of the American Association for Cancer Research, 2012; 18(7): 2024-31.
Walter Franziska, Cloughesy Timothy, Walter Martin A, Lai Albert, Nghiemphu Phioanh, Wagle Naveed, Fueger Barbara, Satyamurthy Nagichettiar, Phelps Michael E, Czernin Johannes   Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012; 53(3): 393-8.
Lee Jason T, Campbell Dean O, Satyamurthy Nagichettiar, Czernin Johannes, Radu Caius G   Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012; 53(2): 275-80.
Yaghoubi Shahriar S, Campbell Dean O, Radu Caius G, Czernin Johannes   Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications Theranostics, 2012; 2(4): 374-91.
Karantanis Dimitrios, Allen-Auerbach Martin, Czernin Johannes   Sources and resources for oncologists to help answer the question: is PET/CT appropriate for my patient? Hellenic journal of nuclear medicine, 2012; 15(1): 2-8.
Beyer Thomas, Freudenberg Lutz S, Czernin Johannes, Townsend David W   The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond Insights into imaging, 2011; 2(3): 235-246.
Czernin Johannes   The National Oncologic PET Registry (NOPR): A Monumental Effort by a Few Leaders Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018; 59(3): 379.
Beyer Thomas, Townsend David W, Czernin Johannes, Freudenberg Lutz S   The future of hybrid imaging-part 2: PET/CT Insights into imaging, 2011; 2(3): 225-34.
Calais Jeremie, Fendler Wolfgang P, Eiber Matthias, Gartmann Jeannine, Chu Fang-I, Nickols Nicholas G, Reiter Robert E, Rettig Matthew B, Marks Leonard S, Ahlering Thomas E, Huynh Linda M, Slavik Roger, Gupta Pawan, Quon Andrew, Allen-Auerbach Martin S, Czernin Johannes, Herrmann Ken   Impact of Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018; 59(3): 434-441.
Beyer Thomas, Freudenberg Lutz S, Townsend David W, Czernin Johannes   The future of hybrid imaging-part 1: hybrid imaging technologies and SPECT/CT Insights into imaging, 2011; 2(2): 161-9.
Czernin Johannes   The National Oncology PET Registry (NOPR): A monumental effort by a few leaders Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018; 59(2): 230-237.
Fendler Wolfgang P, Stuparu Andreea D, Evans-Axelsson Susan, Lückerath Katharina, Wei Liu, Kim Woosuk, Poddar Soumya, Said Jonathan, Radu Caius G, Eiber Matthias, Czernin Johannes, Slavik Roger, Herrmann Ken   Establishing Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017; 58(11): 1786-1792.
Calais Jeremie, Czernin Johannes, Eiber Matthias, Fendler Wolfgang P, Gartmann Jeannine, Heaney Anthony P, Hendifar Andrew E, Pisegna Joseph R, Hecht J Randolph, Wolin Edward M, Slavik Roger, Gupta Pawan, Quon Andrew, Schiepers Christiaan, Allen-Auerbach Martin S, Herrmann Ken   Most of the Intended Management Changes After Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017; 58(11): 1793-1796.
Czernin Johannes   Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017; 58(10): 1535.